Skip to main content
. 2021 Apr 18;38(5):2673–2688. doi: 10.1007/s12325-021-01727-5

Table 4.

Adverse drug reactions, overall and stratified by duration of ITP at romiplostim initiation

Overall
(n = 340)
ITP duration (months)
 < 3
(n = 64)
3–12
(n = 50)
 > 12
(n = 226)
Any ADR, % (95% CI) 15.8 (12–19.5) 10.9 (3.1–18.8) 17 (7.3–26.7) 16.7 (11.9–21.6)
Bone marrow ADRs, % (95% CI) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
Thrombotic ADRs, % (95% CI) 1.3 (0–2.6) 1.8 (0–5.1) 0 (0–0) 1.4 (0–3.1)

ADR adverse drug reaction, CI 95% confidence interval